Abeona Therapeutics Inc vs Intuit Inc. — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Intuit Inc. trades at $333.5 (market cap $92.03B). The key difference: Intuit Inc. is far larger — about 218.5× Abeona Therapeutics Inc's market cap, and Intuit Inc. pays a 1.43% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | INTU | |
|---|---|---|
Market Cap | $421.19M | $92.03B |
Sector | Health | Technology |
52-Week High | $7.45 | $717.21 |
52-Week Low | $4.17 | $255.07 |
Enterprise Value | $276.10M | $90.49B |
Dividend Yield | — | 1.43% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Intuit (INTU) trades at $336.44, up 3.44% today, with a bullish technical signal and strong earnings beats in recent quarters. Revenue grew to $18.83B in 2025, with a net income margin of 20.54%, while analyst consensus is a Buy with a $401 price target. However, recent news highlights a 20% stock drop and securities fraud investigations related to TurboTax pricing issues, creating near-term uncertainty.
The outlook is mixed: strong fundamentals and AI-driven growth in financial software support upside, but legal risks and investor sentiment pressure pose challenges. Valuation metrics like a P/E of 20.4 appear reasonable if execution continues, yet volatility may persist until legal concerns resolve.
Trailing returns across standard periods
Latest headlines on both assets
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →Intuit is a provider of small-business accounting software (QuickBooks), personal tax solutions (TurboTax), and professional tax offerings (Lacerte). Founded in the mid-1980s, Intuit controls the majority of U.S. market share for small-business accounting and DIY tax-filing software.
Read more on INTU →